Bacterial vaginosis physical examination

Revision as of 19:30, 13 September 2017 by Mmir (talk | contribs)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Vaginitis Main Page

Bacterial vaginosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial vaginosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Amsel Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial vaginosis physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial vaginosis physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial vaginosis physical examination

CDC on Bacterial vaginosis physical examination

Bacterial vaginosis physical examination in the news

Blogs on Bacterial vaginosis physical examination

Directions to Hospitals Treating Bacterial vaginosis

Risk calculators and risk factors for Bacterial vaginosis physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Common genital examination of patients with bacterial vaginosis is usually remarkable for fishy-odor from the vagina, thin, white/gray vaginal discharge, and lack of significant vulvovaginal inflammation.[1]

Physical Examination

Genital examination

A genital examination of patients with bacterial vaginosis is usually remarkable for:

  • Fishy-odor emitted from the vagina
  • Thin, white/gray, homogeneous vaginal discharge
  • Lack of significant vulvovaginal inflammation

References

  1. Center for Disease Control and prevention. Mortality and morbidity weekly reports. Sexually transmitted disease treatment guideline. (2015) https://www.cdc.gov/std/tg2015/tg-2015-print.pdf Accessed on October 20, 2016

Template:WH Template:WS